SearchDictionaryMobileLogin

Direct inhibition of cardiac hyperpolarization-activated cyclic nucleotide-gated pacemaker channels by clonidine.

AbstractBACKGROUND: Inhibition of cardiac sympathetic tone represents an important strategy for treatment of cardiovascular disease, including arrhythmia, coronary heart disease, and chronic heart failure. Activation of presynaptic alpha2-adrenoceptors is the most widely accepted mechanism of action of the antisympathetic drug clonidine; however, other target proteins have been postulated to contribute to the in vivo actions of clonidine. METHODS AND RESULTS: To test whether clonidine elicits pharmacological effects independent of alpha2-adrenoceptors, we have generated mice with a targeted deletion of all 3 alpha2-adrenoceptor subtypes (alpha2ABC-/-). Alpha2ABC-/- mice were completely unresponsive to the analgesic and hypnotic effects of clonidine; however, clonidine significantly lowered heart rate in alpha2ABC-/- mice by up to 150 bpm. Clonidine-induced bradycardia in conscious alpha2ABC-/- mice was 32.3% (10 microg/kg) and 26.6% (100 microg/kg) of the effect in wild-type mice. A similar bradycardic effect of clonidine was observed in isolated spontaneously beating right atria from alpha2ABC-knockout and wild-type mice. Clonidine inhibited the native pacemaker current (I(f)) in isolated sinoatrial node pacemaker cells and the I(f)-generating hyperpolarization-activated cyclic nucleotide-gated (HCN) 2 and HCN4 channels in transfected HEK293 cells. As a consequence of blocking I(f), clonidine reduced the slope of the diastolic depolarization and the frequency of pacemaker potentials in sinoatrial node cells from wild-type and alpha2ABC-knockout mice. CONCLUSIONS: Direct inhibition of cardiac HCN pacemaker channels contributes to the bradycardic effects of clonidine gene-targeted mice in vivo, and thus, clonidine-like drugs represent novel structures for future HCN channel inhibitors.
AuthorsAnne Knaus, Xiangang Zong, Nadine Beetz, Roland Jahns, Martin J Lohse, Martin Biel, Lutz Hein (Affiliation: Department of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany.)
JournalCirculation (Circulation) Vol. 115 Issue 7 Pg. 872-80 (Feb 20 2007) ISSN: 1524-4539 United States
PMID17261653 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cardiovascular Agents
  • Cyclic Nucleotide-Gated Cation Channels
  • HCN2 potassium channel
  • HCN4 protein, human
  • Ion Channels
  • Muscle Proteins
  • Clonidine
Topics
  • Animals
  • Bradycardia (chemically induced)
  • Cardiovascular Agents (pharmacology)
  • Cell Line
  • Clonidine (pharmacology)
  • Cyclic Nucleotide-Gated Cation Channels
  • Female
  • Ion Channels (antagonists & inhibitors, drug effects)
  • Male
  • Mice
  • Mice, Inbred Strains
  • Muscle Proteins (antagonists & inhibitors, drug effects)
  • Sympathetic Nervous System (drug effects)